News

23/11/2021

Stewardship Prize Winner Announced

Prize Winner: Infectious Diseases Institute - Kampala, Uganda After careful review, the AMR Industry Alliance is proud to announce the Infectious Diseases Institute (IDI) in Kampala, Uganda as the...

Read more
22/11/2021

Thomas Cueni

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “We all have a shared responsibility to find ways f...

Read more
22/11/2021

Dr. John Rex

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “Antibiotics only have a finite lifetime. We only g...

Read more
22/11/2021

Manjit Singh

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “The AMR Industry Alliance is making a next big ste...

Read more
22/11/2021

Dr. Larry Kerr

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   "Public-private partnerships are one of the invaluabl...

Read more
18/11/2021

Dr. Manica Balasegaram

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021 "New treatments will only be successful if they are available t...

Read more
18/11/2021

Dr. Ramanan Laxminarayan

Building Health System Resilience: The Role of Antimicrobials A video series celebrating World Antimicrobial Awareness Week 2021   “We certainly aren’t where we need to be with res...

Read more
09/11/2021

World Antimicrobial Awareness Week (WAAW) 2021

As part of this year’s World Antimicrobial Awareness Week (WAAW) the AMR Industry Alliance will host a virtual panel session on Supporting the optimal use of antimicrobial medicines through inno...

Read more
26/08/2021

Request for Proposals: Developing a sustainability framework for off-patent antibiotics

The AMR Industry Alliance is currently seeking proposals to support the work of its Access Working Group. The duration of this consultancy is defined for a period of approximately 6 months, starting 22 October 2021 (or as soon as the procurement process is completed) and ending 28 February 2022 when the deliverables have been approved by the AMR Industry Alliance Board. The consultancy will be conducted under the overall guidance of the AMR Industry Alliance Access Working Group Lead and Core Team. The Consultancy will be home-based, from any country.

Read more
21/06/2021

Request for Proposals: Regulatory Landscape Phase 1

  To view as a PDF, click here. Overview The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrobial resist...

Read more
21/06/2021

Request for Proposals: Regulatory Landscape Phase 2

  To view as a PDF, click here. Overview   The AMR Industry Alliance is one of the largest private sector coalitions established to provide sustainable solutions to curb antimicrob...

Read more
20/06/2021

Stewardship Prize: Strengthening Stewardship and Appropriate Use in Low- and Middle-Income Countries

About the Stewardship Prize While significant efforts have been initiated across low- and middle-income countries (LMICs) to address AMR stewardship and appropriate use of antibiotics, limited resour...

Read more
16/01/2020

AMR life sciences industry 2020 report: Successes and setbacks in fighting superbugs 

 AMR Industry Alliance reports breakthroughs in the responsible manufacturing of antibiotics and positive steps to improve how patients access and use antibiotics. But its report also highlights conc...

Read more
18/11/2019

AMR Industry Alliance Round-Up, Issue No.3, November 2019

Welcome to the third issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as p...

Read more
18/09/2019

AMR Industry Alliance Round-Up, Issue No.2, September 2019

Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...

Read more
29/07/2019

New brochure to discover the AMR Industry Alliance in 2 minutes

Representing more than 100 biotechnology, diagnostics, generics and research-based pharmaceutical companies and associations, the AMR Industry Alliance is one of the largest private sector coalitions...

Read more
13/06/2019

AMR Industry Alliance Round-Up, Issue No.1, June 2019

  This is the first issue of "Alliance Round-Up" written for the more than 100 biotech, diagnostic, generic and pharma companies who are members of the AMR Industry Alliance, as well as people...

Read more
12/11/2018

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all st...

Read more
08/06/2018

Multiple Alliance Members Co-sign the Canadian Declaration on Antimicrobial Resistance

The International Council of Biotechnology Associations (ICBA) supports the Canadian Declaration on Combatting Antimicrobial Resistance, signed by biopharmaceutical and diagnostic companies in Canada...

Read more
18/01/2018

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The re...

Read more
18/05/2017

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance....

Read more
20/09/2016

AMR Roadmap Launched

Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020...

Read more
21/01/2016

AMR Declaration Launched

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in...

Read more